Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 14/20 | 0.55 |
| ▸ | EGFR | P00533 | 14/20 | 0.55 |
| ▸ | SRC | P12931 | 2/20 | 0.50 |
| ▸ | ITK | Q08881 | 1/20 | 0.44 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.42 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.42 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28392095 | 0.93 | BTK (0.55) | BTKEGFRSRCFGFR1FGFR4 | |
| SCHEMBL17447811 | 0.93 | BTK (0.55) | BTKEGFRSRCFGFR1FGFR4 | |
| SCHEMBL17447837 | 0.89 | BTK (0.54) | BTKEGFRSRCITKFGFR1 | |
| SCHEMBL17447829 | 0.89 | BTK (0.54) | BTKEGFRSRCITKFGFR1 | |
| SCHEMBL17447806 | 0.88 | BTK (0.58) | BTKEGFRSRCFGFR1FGFR4 | |
| SCHEMBL17447843 | 0.88 | BTK (0.58) | BTKEGFRSRCFGFR1FGFR4 | |
| SCHEMBL17447879 | 0.88 | BTK (0.58) | BTKEGFRSRCFGFR1FGFR4 | |
| SCHEMBL28389981 | 0.88 | BTK (0.58) | BTKEGFRSRCFGFR1FGFR4 | |
| SCHEMBL17447850 | 0.88 | BTK (0.58) | BTKEGFRSRCFGFR1FGFR4 | |
| SCHEMBL17447848 | 0.87 | BTK (0.57) | BTKEGFRSRCFGFR1FGFR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106687446-B | 5-amino-4-carbamoyl-pyrazole compounds as selective and irreversible kinase inhibitors of T790M/WT-EGFR and uses thereof | 百济神州(北京)生物科技有限公司 | 2020-04-28 | — | — | CN | disclosed |
| WO-2016008411-A1 | 5-AMINO-4-CARBAMOYL-PYRAZOLE COMPOUNDS AS SELECTIVE AND IRREVERSIBLE T790M OVER WT-EGFR KINASE INHIBITORS AND USE THEREOF | BEIGENE, LTD. (KY) | 2016-01-21 | — | — | WO | disclosed |